{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:14:28Z","timestamp":1788588868727,"version":"build-2803163510"},"reference-count":45,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,3,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Adoptive cellular therapies with T cells are increasingly used to treat a variety of conditions. For instance, in a recent phase 1\/2 trial, we prophylactically administered multivirus-specific T-cell products to protect recipients of T-cell\u2013depleted allogeneic stem cell grafts against viral reactivation. To establish treatment efficacy, it is important to determine the fate of the individual transferred T-cell populations. However, it is difficult to unequivocally distinguish progeny of the transferred T-cell products from recipient- or stem cell graft\u2013derived T cells that survived T-cell depletion during conditioning or stem cell graft manipulation. Using messenger RNA sequencing of the T-cell receptor \u03b2-chains of the individual virus-specific T-cell populations within these T-cell products, we were able to track the multiple clonal virus-specific subpopulations in peripheral blood and distinguish recipient- and stem cell graft\u2013derived virus-specific T cells from the progeny of the infused T-cell products. We observed in\u00a0vivo expansion of virus-specific T cells that were exclusively derived from the T-cell products with similar kinetics as the expansion of virus-specific T\u00a0cells that could also be detected before the T-cell product infusion. In addition, we demonstrated persistence of virus-specific T cells derived from the T-cell products in most patients who did not show viral reactivation. This study demonstrates that virus-specific T\u00a0cells from prophylactically infused multiantigen-specific T-cell products can expand in response to antigen encounter in\u00a0vivo and even persist in the absence of early viral reactivation.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022007270","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T14:58:46Z","timestamp":1663599526000},"page":"812-827","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":9,"title":["Tracking the progeny of adoptively transferred virus-specific T cells in patients posttransplant using TCR sequencing"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5699-7087","authenticated-orcid":false,"given":"W.","family":"Huisman","sequence":"first","affiliation":[{"name":"1Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"2Department of Hematopoiesis, Sanquin Research and Landsteiner Laboratory for Blood Cell Research, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5101-2154","authenticated-orcid":false,"given":"M. C. J.","family":"Roex","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5195-1525","authenticated-orcid":false,"given":"L.","family":"Hageman","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8446-5133","authenticated-orcid":false,"given":"E. A. S.","family":"Koster","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A. J.","family":"Veld","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hoogstraten","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9670-4664","authenticated-orcid":false,"given":"P.","family":"van Balen","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. M.","family":"van Egmond","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6386-4517","authenticated-orcid":false,"given":"C. A. M.","family":"van Bergen","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Einsele","sequence":"additional","affiliation":[{"name":"3Department of Internal Medicine II, University Hospital W\u00fcrzburg, W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Germeroth","sequence":"additional","affiliation":[{"name":"4Juno Therapeutics GmbH, a Celgene company, Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2491-4566","authenticated-orcid":false,"given":"D.","family":"Amsen","sequence":"additional","affiliation":[{"name":"2Department of Hematopoiesis, Sanquin Research and Landsteiner Laboratory for Blood Cell Research, Amsterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9819-4813","authenticated-orcid":false,"given":"J. H. F.","family":"Falkenburg","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9042-6459","authenticated-orcid":false,"given":"I.","family":"Jedema","sequence":"additional","affiliation":[{"name":"1Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"issue":"4","key":"2023081515552473800_bib1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00428-018-2484-0","article-title":"Adoptive cellular therapies: the current landscape","volume":"474","author":"Rohaan","year":"2019","journal-title":"Virchows Arch"},{"issue":"8","key":"2023081515552473800_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aal2568","article-title":"Tracking the fate and origin of clinically relevant adoptively transferred CD8(+) T cells in vivo","volume":"2","author":"Chapuis","year":"2017","journal-title":"Sci Immunol"},{"key":"2023081515552473800_bib3","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1084\/jem.20040613","article-title":"Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA-peptide tetramers","volume":"202(3)","author":"Cobbold","year":"2005","journal-title":"J Exp Med"},{"issue":"1","key":"2023081515552473800_bib4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2006.06108.x","article-title":"Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation","volume":"134","author":"Feuchtinger","year":"2006","journal-title":"Br J Haematol"},{"issue":"1","key":"2023081515552473800_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-065X.1997.tb00984.x","article-title":"Adoptive cellular immunotherapy for EBV lymphoproliferative disease","volume":"157","author":"Heslop","year":"1997","journal-title":"Immunol Rev"},{"issue":"26","key":"2023081515552473800_bib6","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.1182\/blood-2013-02-486324","article-title":"Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation","volume":"121","author":"Leen","year":"2013","journal-title":"Blood"},{"issue":"10","key":"2023081515552473800_bib7","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/nm1475","article-title":"Monoculture-derived T lymphocytes specific for multiple viruses expand and produce clinically relevant effects in immunocompromised individuals","volume":"12","author":"Leen","year":"2006","journal-title":"Nat Med"},{"issue":"5","key":"2023081515552473800_bib8","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.coi.2009.08.006","article-title":"Pathogen specific T-lymphocytes for the reconstitution of the immunocompromised host","volume":"21","author":"Li Pira","year":"2009","journal-title":"Curr Opin Immunol"},{"issue":"8","key":"2023081515552473800_bib9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/CJI.0b013e31826e35f6","article-title":"Effective treatment of refractory CMV reactivation after allogeneic stem cell transplantation with in vitro-generated CMV pp65-specific CD8+ T-cell lines","volume":"35","author":"Meij","year":"2012","journal-title":"J Immunother"},{"issue":"1\u20133","key":"2023081515552473800_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12026-007-0059-2","article-title":"Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants","volume":"38","author":"O\u2019Reilly","year":"2007","journal-title":"Immunol Res"},{"issue":"5067","key":"2023081515552473800_bib11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1126\/science.1352912","article-title":"Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones","volume":"257","author":"Riddell","year":"1992","journal-title":"Science"},{"issue":"16","key":"2023081515552473800_bib12","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","article-title":"Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor","volume":"333","author":"Walter","year":"1995","journal-title":"N Engl J Med"},{"issue":"3","key":"2023081515552473800_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1586\/erv.10.169","article-title":"ELISpot for measuring human immune responses to vaccines","volume":"10","author":"Slota","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"2023081515552473800_bib14","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/cyto.a.20549","article-title":"How many events is enough? Are you positive?","volume":"73A","author":"Roederer","year":"2008","journal-title":"Cytometry"},{"issue":"5","key":"2023081515552473800_bib15","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm0596-551","article-title":"Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes","volume":"2","author":"Heslop","year":"1996","journal-title":"Nat Med"},{"issue":"12","key":"2023081515552473800_bib16","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1086\/648422","article-title":"Cytomegalovirus-specific T cell immunotherapy promotes restoration of durable functional antiviral immunity following allogeneic stem cell transplantation","volume":"49","author":"Peggs","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"1","key":"2023081515552473800_bib17","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12896-017-0379-9","article-title":"Overview of methodologies for T-cell receptor repertoire analysis","volume":"17","author":"Rosati","year":"2017","journal-title":"BMC Biotechnol"},{"issue":"11","key":"2023081515552473800_bib18","doi-asserted-by":"crossref","first-page":"3916","DOI":"10.1182\/blood.V99.11.3916","article-title":"Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy","volume":"99","author":"Einsele","year":"2002","journal-title":"Blood"},{"issue":"4","key":"2023081515552473800_bib19","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jcyt.2018.01.008","article-title":"The simultaneous isolation of multiple high and low frequent T-cell populations from donor peripheral blood mononuclear cells using the major histocompatibility complex I-Streptamer isolation technology","volume":"20","author":"Roex","year":"2018","journal-title":"Cytotherapy"},{"key":"2023081515552473800_bib20","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41375-019-0600-z","article-title":"Generation and infusion of multi-antigen-specific T cells to prevent complications early after T-cell depleted allogeneic stem cell transplantation-a phase I\/II study","volume":"34(3)","author":"Roex","year":"2020","journal-title":"Leukemia"},{"key":"2023081515552473800_bib21","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3109\/10428194.2013.828353","article-title":"Template-switching anchored polymerase chain reaction reliably amplifies functional lambda light chain transcripts of malignant lymphoma","volume":"55(5)","author":"Koning","year":"2014","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"2023081515552473800_bib22","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1172\/JCI86175","article-title":"Selective graft-versus-leukemia depends on magnitude and diversity of the alloreactive T\u00a0cell response","volume":"127","author":"van Bergen","year":"2017","journal-title":"J Clin Invest"},{"key":"2023081515552473800_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.851868","article-title":"Public T-cell receptors (TCRs) revisited by analysis of the magnitude of identical and highly-similar TCRs in virus-specific T-cell repertoires of healthy individuals","volume":"13","author":"Huisman","year":"2022","journal-title":"Front Immunol"},{"key":"2023081515552473800_bib24","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/nmeth.3364","article-title":"MiXCR: software for comprehensive adaptive immunity profiling","volume":"12 (5)","author":"Bolotin","year":"2015","journal-title":"Nat Methods"},{"issue":"1","key":"2023081515552473800_bib25","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jcyt.2020.08.003","article-title":"Effect of alemtuzumab-based T-cell depletion on graft compositional change in vitro and immune reconstitution early after allogeneic stem cell transplantation","volume":"23","author":"Roex","year":"2021","journal-title":"Cytotherapy"},{"issue":"6","key":"2023081515552473800_bib26","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.4049\/jimmunol.1701018","article-title":"High mutation frequency of the PIGA gene in T cells results in reconstitution of GPI anchor(-)\/CD52(-) T\u00a0cells that can give early immune protection after alemtuzumab-based T cell-depleted allogeneic stem cell transplantation","volume":"200","author":"Loeff","year":"2018","journal-title":"J Immunol"},{"issue":"18","key":"2023081515552473800_bib27","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1182\/blood-2012-08-448977","article-title":"Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation","volume":"121","author":"Blyth","year":"2013","journal-title":"Blood"},{"issue":"20","key":"2023081515552473800_bib28","doi-asserted-by":"crossref","first-page":"4360","DOI":"10.1182\/blood-2010-01-262089","article-title":"Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation","volume":"116","author":"Feuchtinger","year":"2010","journal-title":"Blood"},{"issue":"11","key":"2023081515552473800_bib29","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1038\/mt.2013.151","article-title":"Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant","volume":"21","author":"Gerdemann","year":"2013","journal-title":"Mol Ther"},{"issue":"9","key":"2023081515552473800_bib30","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.bbmt.2015.05.015","article-title":"Immunotherapy with donor T cells sensitized with overlapping pentadecapeptides for treatment of persistent cytomegalovirus infection or viremia","volume":"21","author":"Koehne","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"2023081515552473800_bib31","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1016\/j.jcyt.2015.07.005","article-title":"Addition of varicella zoster virus-specific T cells to cytomegalovirus, Epstein-Barr virus and adenovirus tri-specific T cells as adoptive immunotherapy in patients undergoing allogeneic hematopoietic stem cell transplantation","volume":"17","author":"Ma","year":"2015","journal-title":"Cytotherapy"},{"issue":"4","key":"2023081515552473800_bib32","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/cid\/ciy549","article-title":"Autologous adoptive T-cell therapy for recurrent or drug-resistant cytomegalovirus complications in solid organ transplant recipients: a single-arm open-label phase I clinical trial","volume":"68","author":"Smith","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"242","key":"2023081515552473800_bib33","doi-asserted-by":"crossref","first-page":"242ra83","DOI":"10.1126\/scitranslmed.3008825","article-title":"Activity of broad-spectrum T cells as treatment for AdV, EBV, CMV, BKV, and HHV6 infections after HSCT","volume":"6","author":"Papadopoulou","year":"2014","journal-title":"Sci Transl Med"},{"issue":"2","key":"2023081515552473800_bib34","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/bjh.16053","article-title":"T-cell receptor sequencing demonstrates persistence of virus-specific T cells after antiviral immunotherapy","volume":"187","author":"Keller","year":"2019","journal-title":"Br J Haematol"},{"issue":"11","key":"2023081515552473800_bib35","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1111\/ajt.12431","article-title":"TCR repertoire analysis by next generation sequencing allows complex differential diagnosis of T cell-related pathology","volume":"13","author":"Dziubianau","year":"2013","journal-title":"Am J Transplant"},{"issue":"5","key":"2023081515552473800_bib36","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1312239","article-title":"Ewing sarcoma partial regression without GvHD by chondromodulin-I\/HLA-A\u221702:01-specific allorestricted T cell receptor transgenic T cells","volume":"6","author":"Thiel","year":"2017","journal-title":"Oncoimmunology"},{"issue":"2","key":"2023081515552473800_bib37","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/cei.12887","article-title":"T cell receptor repertoires after adoptive transfer of expanded allogeneic regulatory T cells","volume":"187","author":"Theil","year":"2017","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"2023081515552473800_bib38","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1182\/blood-2014-07-589150","article-title":"CMV promotes recipient T-cell immunity following reduced-intensity T-cell-depleted HSCT, significantly modulating chimerism status","volume":"125","author":"Sellar","year":"2015","journal-title":"Blood"},{"issue":"273","key":"2023081515552473800_bib39","doi-asserted-by":"crossref","first-page":"273ra13","DOI":"10.1126\/scitranslmed.3010314","article-title":"In vivo tracking of T cells in humans unveils decade-long survival and activity of genetically modified T memory stem cells","volume":"7","author":"Biasco","year":"2015","journal-title":"Sci Transl Med"},{"issue":"5796","key":"2023081515552473800_bib40","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1126\/science.1129003","article-title":"Cancer regression in patients after transfer of genetically engineered lymphocytes","volume":"314","author":"Morgan","year":"2006","journal-title":"Science"},{"issue":"1","key":"2023081515552473800_bib41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/cid\/ciq042","article-title":"Directly selected cytomegalovirus-reactive donor T cells confer rapid and safe systemic reconstitution of virus-specific immunity following stem cell transplantation","volume":"52","author":"Peggs","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"9","key":"2023081515552473800_bib42","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1053\/bbmt.2002.v8.pm12374455","article-title":"Cytomegalovirus-specific CD4+ and CD8+ T-cells follow a similar reconstitution pattern after allogeneic stem cell transplantation","volume":"8","author":"Foster","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"issue":"26","key":"2023081515552473800_bib43","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1182\/blood-2016-01-628982","article-title":"T\u00a0cells for viral infections after allogeneic hematopoietic stem cell transplant","volume":"127","author":"Bollard","year":"2016","journal-title":"Blood"},{"issue":"128","key":"2023081515552473800_bib44","doi-asserted-by":"crossref","first-page":"128ra42","DOI":"10.1126\/scitranslmed.3003647","article-title":"T cell receptor \u03b1\u03b2 diversity inversely correlates with pathogen-specific antibody levels in human cytomegalovirus infection","volume":"4","author":"Wang","year":"2012","journal-title":"Sci Transl Med"},{"key":"2023081515552473800_bib45","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.3389\/fimmu.2018.01378","article-title":"Optimized peptide-MHC multimer protocols for detection and isolation of autoimmune T-cells","volume":"9","author":"Dolton","year":"2018","journal-title":"Front Immunol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/5\/812\/2071443\/blooda_adv-2022-007270-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/5\/812\/2071443\/blooda_adv-2022-007270-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T16:11:53Z","timestamp":1692115913000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/5\/812\/486656\/Tracking-the-progeny-of-adoptively-transferred"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,3,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022007270","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,3]]}}}